CN106501244A - Serum copper ions quantitative detecting reagent - Google Patents

Serum copper ions quantitative detecting reagent Download PDF

Info

Publication number
CN106501244A
CN106501244A CN201610872679.2A CN201610872679A CN106501244A CN 106501244 A CN106501244 A CN 106501244A CN 201610872679 A CN201610872679 A CN 201610872679A CN 106501244 A CN106501244 A CN 106501244A
Authority
CN
China
Prior art keywords
buffer solution
reagent
copper ions
quantitative detecting
bacteriostatic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610872679.2A
Other languages
Chinese (zh)
Inventor
胡露群
董露蓓
吴永菲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ningbo Purui Bai Biotechnology Ltd By Share Ltd
Original Assignee
Ningbo Purui Bai Biotechnology Ltd By Share Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ningbo Purui Bai Biotechnology Ltd By Share Ltd filed Critical Ningbo Purui Bai Biotechnology Ltd By Share Ltd
Priority to CN201610872679.2A priority Critical patent/CN106501244A/en
Publication of CN106501244A publication Critical patent/CN106501244A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention discloses a kind of serum copper ions quantitative detecting reagent, including reagent R1, reagent R2 and calibration object, it is characterised in that:The reagent R1 includes:Buffer solution, interfacial agent, reaction promoter, stabilizer, bacteriostatic agent, wherein, the pH value of buffer solution is 2.0 5.0;The reagent R2 includes:Buffer solution, 3,5 DiBr PAESA, 0.01 0.1g/L, electrolyte, stabilizer, bacteriostatic agent, wherein, the pH value of buffer solution is 6.0 9.0;The calibration object includes:Buffer solution, copper ion, bacteriostatic agent, wherein, the pH value of buffer solution is 6.0 8.0.Advantage for present invention is:Relatively stable and preferable with atomic absorption method correlation.

Description

Serum copper ions quantitative detecting reagent
Technical field
The present invention relates to reagent technique field, more particularly, to a kind of serum copper ions quantitative detecting reagent.
Background technology
From nineteen twenty-eight it is found that copper be daily ration composition required composition after, up to nineteen fifty copper in Animal nutrition Effect just little by little recognized.Copper is one of trace element necessary to livestock and poultry, and it is tyrosinase, monoamine oxidase, surpasses The constituent of multiple copper enzymes such as superoxide dismutase, cytochrome oxidase, while also participate in cromoci, Vitamin C Acid oxidase, the synthesis of galactase, thus with wide biological effect.Serum copper is copper in reflection livestock and poultry body One important parameter of content, and carry out an important indicator of biochemistry test.
Copper is content occupies second in human body essential trace element, is one group in about 100 150mg of people's in-vivo content The part of important enzyme, including CER (ferrous oxidase), superoxide dismutase, cytochrome oxidase, bad ammonia Acid oxidase, dopamine β-hydroxylase and tyrosinase.
Serum copper increases and sees:Oral contraceptive, estrin treatment, Hodgkin's disease, leukaemia and other many malignant diseases Change, megaloblastic anemia, alpastic anemia, hyperpigmentary disorders, rheumatic fever, heavy type and minor thalassemia, wound And collagenosis.
Serum copper reduces seeing:Hepatolenticular degeneration (hepatolenticular degeneration), Menkes or silk volume syndrome, fire victim, certain A little hypoferric anemia, protein malnutrition and chronic ischemic heart diseases etc..
Clinical assays serum copper method mainly has atomic absorption spectrophotometry and colorimetric method at present.Atomic absorption method spirit Quick, special, but expensive atomic absorption spectrophotometer is needed, and cumbersome, time-consuming, clinical practice is less.Chemical method Easy to operate, reagent is easy to get, and is easier to use in clinical expansion.
Content of the invention
It is an object of the invention to provide a kind of serum copper ions quantitative detecting reagent, it has relatively stable, and and atom The characteristics of absorption process correlation is preferable.
The technical solution adopted in the present invention is:
Serum copper ions quantitative detecting reagent, including reagent R1, reagent R2 and calibration object, it is characterised in that:
The reagent R1 includes:Buffer solution 50-200mmol, interfacial agent 2.0-20.0g/L, reaction promoter 2.0- 12.0g/L, stabilizer 0.1-20.0g/L, bacteriostatic agent 0.1-10.0g/L, wherein, the pH value of buffer solution is 2.0-5.0;
The reagent R2 includes:Buffer solution 50-500mmol, 3,5-DiBr-PAESA 0.01-0.1g/L, electrolyte 100- 400mmol, stabilizer 0.1-20.0g/L, bacteriostatic agent 0.1-10.0g/L, wherein, the pH value of buffer solution is 6.0-9.0;
The calibration object includes:Buffer solution 20-300mmol, 20-60 μm of ol/L of copper ion, bacteriostatic agent 0.1-10.0g/L, Wherein, the pH value of buffer solution is 6.0-8.0.
The buffer solution is Chinese holly edge acid buffer, acetate buffer, HEPES buffer solution, the one kind in PIPES buffer solutions.
The interfacial agent be Tween 20, Tween40, Span20, Span40, Span80, TritonX-100, One kind in 20AB.
The reaction promoter is SDS, Brij 35, KAO 24B, one or more in methyl alcohol.
The electrolyte be sodium ion, potassium ion, magnesium ion, one or more in calcium ion.
The stabilizer be uric acid, lipoic acid, ascorbic acid, sodium ascorbate, one or more in hydroxylamine hydrochloride.
The bacteriostatic agent is methyl alcohol, potassium sorbate, Proclin200, Proclin300, the one kind in gentamicin.
Advantage for present invention is:
1st, detect quick.Can be grasped using automatic biochemistry analyzer using the serum copper ions quantitative detecting reagent of the present invention Make, can be carried out with other detection projects simultaneously, each pattern detection time is shortened in 10min, is detected fast and convenient.
2nd, detection sensitivity ratio is high.The present invention serum copper ions quantitative detecting reagent by Reasonable adjustment reagent buffer, The proportioning of the compositions such as interfacial agent, improves the sensitivity of reaction.
3rd, range of linearity width.The range of linearity of the serum copper ions quantitative detecting reagent of the present invention is 3-78.5 μm of ol/L, Normal population term of reference is the male sex:11.0-22.0 μm ol/L, women:12.6-24.4 μm ol/L, children:12.6-29.9μ Mol/L, disclosure satisfy that clinical needs.
4th, relatively stable.The each composition proportion of serum copper ions quantitative detecting reagent of the invention is more excellent, and reagent is close at 2-8 DEG C Can stablize 12 months under the conditions of closing, after uncapping, store 2-8 DEG C, R1 stablizes 20 days, and R2 stablizes 20 days.
5th, correlation is preferable.Through actual verification, the serum copper ions quantitative detecting reagent and atomic absorption method of the present invention Coefficient correlation be about 0.9658, illustrate that the reagent and atomic absorption method have preferably correlation.
Description of the drawings
The present invention is further described with reference to the accompanying drawings and examples:
Fig. 1 is that to carry out 40 parts of pattern detection results to contrast agents related for the serum copper ions quantitative detecting reagent of the present invention Property test graph of a relation.
Specific embodiment
Embodiment 1
Serum copper ions quantitative detecting reagent, including reagent R1, reagent R2 and calibration object.
Specifically:
Reagent R1 includes:Buffer solution 150mmol, interfacial agent 5.5g/L, reaction promoter 8g/L, stabilizer 10g/L, Bacteriostatic agent 0.8g/L.Wherein, buffer solution adopts pH value sour for 2.8 Chinese holly edge, and interfacial agent is using Triton X-100, reaction Accelerator adopts SDS, stabilizer to adopt sodium ascorbate, bacteriostatic agent to adopt methyl alcohol.
Reagent R2 includes:Buffer solution 300mmol, 3,5-DiBr-PAESA 0.08g/L, electrolyte 150mmol, stabilizer 3g/L, bacteriostatic agent 0.9g/L.Wherein, buffer solution adopts pH value sour for 7.8 Chinese holly edge, and electrolyte adopts NaOH, stabilizer Using ascorbic acid, bacteriostatic agent adopts methyl alcohol.
Calibration object includes:Buffer solution 30mmol, 50 μm of ol/L of copper ion, bacteriostatic agent 0.9g/L.Wherein, buffer solution adopts pH It is worth the Chinese holly edge acid for 7.8, copper ion adopts methyl alcohol from copper sulphate, bacteriostatic agent.
Using method:
Instrument:7180 automatic biochemistry analyzer of Hitachi;
Assay method:2 points of end-point methods;
Detection wavelength:570nm;
The Direction of Reaction:Rise reaction;
V samples:VR1:VR2=15 μ l:240μl:60μl;
Calibration and calibrating mode:Calibrated using linear after water and calibration object calibration.
Operating procedure:
Sample and reagent R1 are mixed and are incubated 3-5min after 37 DEG C, read the 1st reading point absorbance A 1, add reagent immediately R2, after mixing, 37 DEG C of incubation 5min, read the 2nd reading point absorbance A 2.
As a result calculate:
Calibrated with water (zero point) using calibration object, by 2 points of absorbance change values (A calibration-A are blank) to its phase Answer concentration to do figure, draw calibration curve.(A samples-A is blank) value according to sample tries to achieve copper ions in sample on calibration curve Content.
Theoretically, as reagent R1 provides the liquid environment of Copper in Serum ion and substrate reactions, with can make The characteristics of copper ion becomes free state.Reagent R2 has the 3,5-DiBr-PAESA for making certain concentration in 2-8 DEG C of preservation condition The characteristics of stably preserving down.Especially 3,5-DiBr-PAESA is only reacted with copper ion, is not reacted with other ions.The calibration object Middle people's copper ion source is in copper sulphate or copper chloride.
When specifically used, the serum copper ions quantitative detecting reagent adopts colorimetric method, reaction principle be copper in sample from After son is met in a liquid with reagent R1, dissociate with the material that script is combined, substrate (3,5-DiBr- corresponding to reagent PAESA) meet in the liquid phase and react, make absorbance change.The absorbance change in the presence of enough substrates with In sample, the concentration of copper ion is proportional, and absorbance change is compared with the calibration object of concentration known, can quantitatively draw sample The content of middle copper ion.
Embodiment 2
Serum copper ions quantitative detecting reagent, including reagent R1, reagent R2 and calibration object.
Specifically:
Reagent R1 includes:Buffer solution 200mmol, interfacial agent 7.0g/L, reaction promoter 7g/L, stabilizer 12g/L, Bacteriostatic agent 0.8g/L.Wherein, buffer solution adopt pH value for 3.6 acetic acid, interfacial agent adopts 20AB, and reaction promoter is adopted SDS, stabilizer adopt ascorbic acid, bacteriostatic agent to adopt Proclin300.
Reagent R2 includes:Buffer solution 200mmol, 3,5-DiBr-PAESA 0.09g/L, electrolyte 150mmol, stabilizer 5g/L, bacteriostatic agent 0.9g/L.Wherein, buffer solution adopt pH value for 7.8 lemon acetic acid, electrolyte adopts NaOH, stabilizer Using uric acid, bacteriostatic agent adopts methyl alcohol.
Calibration object includes:Buffer solution 30mmol, 50 μm of ol/L of copper ion, bacteriostatic agent 0.9g/L.Wherein, buffer solution adopts pH It is worth the Chinese holly edge acid for 7.8, copper ion adopts Proclin200 from copper sulphate, bacteriostatic agent.
Using method, operating procedure, result calculate same as Example 1.
Embodiment 3
Serum copper ions quantitative detecting reagent, including reagent R1, reagent R2 and calibration object.
Specifically:
Reagent R1 includes:Buffer solution 50mmol, interfacial agent 2.0g/L, reaction promoter 2g/L, stabilizer 0.1g/L, Bacteriostatic agent 0.1g/L.Wherein, buffer solution adopts pH value sour for 2 Chinese holly edge, and interfacial agent adopts Tween 20, reaction promoter Using Brij 35, SDS, stabilizer adopts lipoic acid, bacteriostatic agent to adopt potassium sorbate.
Reagent R2 includes:Buffer solution 50mmol, 3,5-DiBr-PAESA 0.01g/L, electrolyte 100mmol, stabilizer 0.1g/L, bacteriostatic agent 0.1g/L.Wherein, buffer solution adopt pH value for 6.0 HEPES buffer solution, electrolyte adopts potassium hydroxide, Stabilizer adopts hydroxylamine hydrochloride, bacteriostatic agent to adopt gentamicin.
Calibration object includes:Buffer solution 20mmol, 20 μm of ol/L of copper ion, bacteriostatic agent 0.1g/L.Wherein, buffer solution adopts pH It is worth the PIPES for 6.0, copper ion adopts gentamicin from copper sulphate, bacteriostatic agent.
Using method, operating procedure, result calculate same as Example 1.
Embodiment 4
Serum copper ions quantitative detecting reagent, including reagent R1, reagent R2 and calibration object.
Specifically:
Reagent R1 includes:Buffer solution 160mmol, interfacial agent 20.0g/L, reaction promoter 12g/L, stabilizer 20g/ L, bacteriostatic agent 10g/L.Wherein, buffer solution adopt pH value for 5.0 acetic acid, using Tween 40, reaction promotes interfacial agent Agent adopts KAO 24B, SDS, lipoic acid and uric acid of the stabilizer using arbitrary proportion combination, bacteriostatic agent to adopt potassium sorbate.
Reagent R2 includes:Buffer solution 500mmol, 3,5-DiBr-PAESA 0.1g/L, electrolyte 400mmol, stabilizer 20.0g/L, bacteriostatic agent 10g/L.Wherein, buffer solution adopt pH value for 9.0 HEPES buffer solution, electrolyte adopts magnesium hydroxide, Stabilizer using arbitrary proportion combination uric acid, lipoic acid, ascorbic acid, sodium ascorbate, hydroxylamine hydrochloride, bacteriostatic agent adopt Proclin300.
Calibration object includes:Buffer solution 300mmol, 60 μm of ol/L of copper ion, bacteriostatic agent 10g/L.Wherein, buffer solution adopts pH It is worth the PIPES for 8.0, copper ion adopts gentamicin from copper sulphate, bacteriostatic agent.
Using method, operating procedure, result calculate same as Example 1.
Embodiment 5
With differing only in for embodiment 1:Interfacial agent adopts Span20, reaction promoter to combine using arbitrary proportion SDS, Brij 35, KAO 24B, electrolyte adopts calcium hydroxide.
Embodiment 6
With differing only in for embodiment 2:Interfacial agent adopts Span40, reaction promoter to combine using arbitrary proportion SDS, Brij 35, KAO 24B, methyl alcohol, electrolyte using arbitrary proportion combination NaOH, potassium hydroxide, hydroxide Magnesium.
Embodiment 7
With differing only in for embodiment 3:Interfacial agent adopts Span80, reaction promoter to combine using arbitrary proportion SDS, methyl alcohol, electrolyte using arbitrary proportion combination potassium hydroxide, calcium hydroxide, stabilizer using arbitrary proportion combination Uric acid, lipoic acid, ascorbic acid, sodium ascorbate, hydroxylamine hydrochloride.
Effect example
1st, study on the stability:
The reagent of embodiment 1 is uncapped, after calibration, is placed in instrument reagent storehouse, determine same quality-control product daily, determine 24 days. As a result, such as table 1, after showing that serum copper ions quantitative detecting reagent of the present invention is uncapped 20 days, measure Quality Control still, in the range of, meets Clinical practice needs.
Table 1:Reagent of the present invention is uncapped estimation of stability
According to preceding method, identical experiment is carried out to the reagent of embodiment 2 to 7, as a result similar to table 1, illustrate to implement The reagent of example 2 to 7 equally has preferably stability.
2nd, correlation is investigated
In this effect example, correlation analysis is to represent mutual linear relation between two variables with coefficient correlation (r), and sentences The statistical method of its level of intimate of breaking.Correlation coefficient r does not have unit, changes in the range of -1+1, its absolute value closer to 1, Linear correlation between two variables is closer, closer to 0, related not closer.If coefficient correlation just, illustrates a variable with another One variable increases and decreases and increases and decreases, and direction is identical;If negative, represent that a variable increases, another variable is reduced, i.e., in opposite direction, but it The relation of (such as various curves) beyond straight line can not being expressed.Correlation coefficient r=0 0.3 represent degree of correlation less than common, related Coefficient r=0.3 0.5 represents that degree of correlation is common, and correlation coefficient r=0.5 0.7 represent degree of correlation significantly, correlation coefficient r =0.7 0.9 represents that degree of correlation is high, and correlation coefficient r=0.9 1.0 represent that degree of correlation is high.
The reagent of Example 2, is compared test with atomic absorption method, contrast agents arrange parameter to specifications, Respectively using each self-check system, to copper ion quantitative determination in identical 40 parts of serum samples.As a result as shown in Table 2 and Figure 1, relate to And 40 samples, coefficient correlation is 0.9658, shows serum copper ions quantitative detecting reagent of the present invention compared with contrast agents, There is good correlation.
Table 2:Reagent of the present invention and 40 parts of pattern detection results of contrast agents (atomic absorption method)
According to preceding method, identical experiment is carried out to the reagent of embodiment 1 and embodiment 3 to 7, as a result similar to table 2, illustrate that embodiment 1 and the reagent of embodiment 3 to 7 equally have good correlation.
The preferred embodiments of the present invention are the foregoing is only, the scope of the claims of the present invention, every utilization is not thereby limited Equivalent structure or equivalent flow conversion that present specification and accompanying drawing are made, or it is related to be directly or indirectly used in other Technical field, be included within the scope of the present invention.

Claims (7)

1. serum copper ions quantitative detecting reagent, including reagent R1, reagent R2 and calibration object, it is characterised in that:
The reagent R1 includes:Buffer solution 50-200mmol, interfacial agent 2.0-20.0g/L, reaction promoter 2.0- 12.0g/L, stabilizer 0.1-20.0g/L, bacteriostatic agent 0.1-10.0g/L, wherein, the pH value of buffer solution is 2.0-5.0;
The reagent R2 includes:Buffer solution 50-500mmol, 3,5-DiBr-PAESA 0.01-0.1g/L, electrolyte 100- 400mmol, stabilizer 0.1-20.0g/L, bacteriostatic agent 0.1-10.0g/L, wherein, the pH value of buffer solution is 6.0-9.0;
The calibration object includes:Buffer solution 20-300mmol, 20-60 μm of ol/L of copper ion, bacteriostatic agent 0.1-10.0g/L, wherein, The pH value of buffer solution is 6.0-8.0.
2. serum copper ions quantitative detecting reagent according to claim 1, it is characterised in that:The buffer solution is the acid of Chinese holly edge One kind in buffer solution, acetate buffer, HEPES buffer solution, PIPES buffer solutions.
3. serum copper ions quantitative detecting reagent according to claim 1, it is characterised in that:The interfacial agent is One kind in Tween 20, Tween40, Span20, Span40, Span80, Triton X-100,20AB.
4. serum copper ions quantitative detecting reagent according to claim 1, it is characterised in that:The reaction promoter is One or more in SDS, Brij 35, KAO 24B, methyl alcohol.
5. serum copper ions quantitative detecting reagent according to claim 1, it is characterised in that:The electrolyte be sodium from One or more in son, potassium ion, magnesium ion, calcium ion.
6. serum copper ions quantitative detecting reagent according to claim 1, it is characterised in that:The stabilizer be uric acid, One or more in lipoic acid, ascorbic acid, sodium ascorbate, hydroxylamine hydrochloride.
7. serum copper ions quantitative detecting reagent according to claim 1, it is characterised in that:The bacteriostatic agent be methyl alcohol, One kind in potassium sorbate, Proclin200, Proclin300, gentamicin.
CN201610872679.2A 2016-09-30 2016-09-30 Serum copper ions quantitative detecting reagent Pending CN106501244A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610872679.2A CN106501244A (en) 2016-09-30 2016-09-30 Serum copper ions quantitative detecting reagent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610872679.2A CN106501244A (en) 2016-09-30 2016-09-30 Serum copper ions quantitative detecting reagent

Publications (1)

Publication Number Publication Date
CN106501244A true CN106501244A (en) 2017-03-15

Family

ID=58293453

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610872679.2A Pending CN106501244A (en) 2016-09-30 2016-09-30 Serum copper ions quantitative detecting reagent

Country Status (1)

Country Link
CN (1) CN106501244A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110596088A (en) * 2019-09-20 2019-12-20 南京林业大学 Method for rapidly determining copper ions
CN111141913A (en) * 2020-01-02 2020-05-12 四川纳海川生物科技有限公司 Ceruloplasmin detection kit and preparation method thereof
CN113720836A (en) * 2021-09-17 2021-11-30 北京安图生物工程有限公司 Kit for detecting serum copper ions and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1635379A (en) * 2004-11-30 2005-07-06 曹建明 Serum copper, iron and zinc rapid sensitive detection kit and preparing method thereof
CN101097220A (en) * 2006-06-28 2008-01-02 温州医学院 Blood serum copper, zincium and iron 5-br-padcap even phase automatic analysis method and liquid stabilizing reagent
CN103760360A (en) * 2013-12-09 2014-04-30 宁波普瑞柏生物技术有限公司 Reagent for quantitative detection of serum alpha 1-antitrypsin
CN105242052A (en) * 2015-10-24 2016-01-13 山东博科生物产业有限公司 Serum copper detection kit suitable for full-automatic biochemical analyzer

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1635379A (en) * 2004-11-30 2005-07-06 曹建明 Serum copper, iron and zinc rapid sensitive detection kit and preparing method thereof
CN101097220A (en) * 2006-06-28 2008-01-02 温州医学院 Blood serum copper, zincium and iron 5-br-padcap even phase automatic analysis method and liquid stabilizing reagent
CN103760360A (en) * 2013-12-09 2014-04-30 宁波普瑞柏生物技术有限公司 Reagent for quantitative detection of serum alpha 1-antitrypsin
CN105242052A (en) * 2015-10-24 2016-01-13 山东博科生物产业有限公司 Serum copper detection kit suitable for full-automatic biochemical analyzer

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
曹建明等: "3 ,5-二溴-2-吡啶偶氮光度法测定血清铜", 《浙江预防医学》 *
罗军等: "3 , 5 -diBr -PADAP 自动化分析法测定血清铜", 《中国冶金工业医学杂志》 *
赵元明 等: "DiBr-PAESA显色法测定血清铜的探讨", 《上海医学检验杂志》 *
郑佳音 等: "单一试剂光度法测定血清铜", 《广东微量元素科学》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110596088A (en) * 2019-09-20 2019-12-20 南京林业大学 Method for rapidly determining copper ions
CN110596088B (en) * 2019-09-20 2021-05-25 南京林业大学 Method for rapidly determining copper ions
CN111141913A (en) * 2020-01-02 2020-05-12 四川纳海川生物科技有限公司 Ceruloplasmin detection kit and preparation method thereof
CN113720836A (en) * 2021-09-17 2021-11-30 北京安图生物工程有限公司 Kit for detecting serum copper ions and preparation method thereof

Similar Documents

Publication Publication Date Title
Bhat et al. Methylglyoxal–an emerging biomarker for diabetes mellitus diagnosis and its detection methods
Jobgen et al. Analysis of nitrite and nitrate in biological samples using high-performance liquid chromatography
Jooste et al. Methods for determination of iodine in urine and salt
Rao et al. Accelerated shelf-life testing of quality loss for a commercial hydrolysed hen egg white powder
Kamruzzaman et al. Microfluidic chip based chemiluminescence detection of L-phenylalanine in pharmaceutical and soft drinks
CN101503732B (en) Glucose oxidase single liquid detection reagent
US10591495B2 (en) Device and methods of using device for detection of hyperammonemia
CN106501244A (en) Serum copper ions quantitative detecting reagent
CN101226198A (en) Enzymatical detection method of saccharify blood albumen as well as liquid stabilising agent
CN112763484B (en) Method for detecting glutathione and/or hydrogen peroxide based on colorimetric biosensor
Odacι et al. Carboxyl esterase-alcohol oxidase based biosensor for the aspartame determination
Vasilarou et al. Enzymatic spectrophotometric reaction rate determination of glucose in fruit drinks and carbonated beverages. An analytical chemistry laboratory experiment for food science-oriented students
Bekdeşer et al. Development of a new catalase activity assay for biological samples using optical CUPRAC sensor
Gasparovic et al. Biomarkers of nitro-oxidation and oxidative stress
Farman et al. Simple kinetic method for assessing catalase activity in biological samples
CN108007922B (en) A kind of kit detecting glucose using luminol chemiluminescence analysis
Hou et al. A new application of papain: As a peroxidase-like catalyst for fluorometric detection of uric acid
CN105334203A (en) Kit for detecting enzymatic activity of biotinidase
Su et al. A colorimetric sensing strategy for detecting 10-hydroxy-2-decenoic acid in royal jelly based on Ag (I)-tetramethylbenzidine
CN106556595B (en) A kind of Picric kinetic method detection kit of strong antijamming capability
Bernt et al. Urea
Martinkova et al. Phone camera detection of glucose blood level based on magnetic particles entrapped inside bubble wrap
TW201120440A (en) Detection method, specimen and detector for redox substance involved in food.
JP4544598B2 (en) Liquid reagent and storage method
Nielsen Instructor’s manual for food analysis: answers to study questions

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170315